Clinical Trial Update: Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Hecolin evaluating immunogenicity and safety in HIV-positive and HIV-negative adults and in children; study status is recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis E

Drugs mentioned

• Hecolin (HEV-239 recombinant vaccine)

Snippet

Sponsor: International Vaccine Institute | Conditions: Hepatitis E Virus Infection | Phase 2 | Status: RECRUITING